STOCK TITAN

Eton Pharmaceuticals Inc - ETON STOCK NEWS

Welcome to our dedicated news page for Eton Pharmaceuticals (Ticker: ETON), a resource for investors and traders seeking the latest updates and insights on Eton Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Eton Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Eton Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.35%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.11%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.09%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.65%
Tags
Eton Pharmaceuticals Inc

Nasdaq:ETON

ETON Rankings

ETON Stock Data

87.85M
19.90M
12.97%
27.94%
0.86%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States
Deer Park

About ETON

eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.